Abstract
Asthma and chronic obstructive pulmonary disease (COPD) are common chronic disorders. Traditionally, asthma has been associated with an eosinophilic inflammation and COPD with neutrophilic inflammation. In this review we will highlight the maturation, recruitment, activation, action and apoptosis of these cells. In addition we will focus on the evidence for their presence in disease and suggest potential new therapeutic interventions.
Keywords: asthma, copd, eosinophils, neutrophils
Current Drug Targets - Inflammation & Allergy
Title: Neutrophils and Eosinophils: Clinical Implications of their Appearance, Presence and Disappearance in Asthma and COPD
Volume: 4 Issue: 4
Author(s): A. P. Watt, B. C. Schock and M. Ennis
Affiliation:
Keywords: asthma, copd, eosinophils, neutrophils
Abstract: Asthma and chronic obstructive pulmonary disease (COPD) are common chronic disorders. Traditionally, asthma has been associated with an eosinophilic inflammation and COPD with neutrophilic inflammation. In this review we will highlight the maturation, recruitment, activation, action and apoptosis of these cells. In addition we will focus on the evidence for their presence in disease and suggest potential new therapeutic interventions.
Export Options
About this article
Cite this article as:
Watt P. A., Schock C. B. and Ennis M., Neutrophils and Eosinophils: Clinical Implications of their Appearance, Presence and Disappearance in Asthma and COPD, Current Drug Targets - Inflammation & Allergy 2005; 4 (4) . https://dx.doi.org/10.2174/1568010054526313
DOI https://dx.doi.org/10.2174/1568010054526313 |
Print ISSN 1568-010X |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-010X |
Related Articles
-
The Metabolic Fate of Apple Polyphenols in Humans
Current Nutrition & Food Science Subcellular Accumulation and Modification of Pharmaceutical Proteins in Different Plant Tissues
Current Pharmaceutical Design Tyrosine Kinase Inhibitor as a new Therapy for Ischemic Stroke and other Neurologic Diseases: is there any Hope for a Better Outcome?
Current Neuropharmacology Personalized Drug Therapy in Cystic Fibrosis: From Fiction to Reality
Current Drug Targets Carbohydrates in Therapeutics
Cardiovascular & Hematological Agents in Medicinal Chemistry Echocardiogram versus Cardiac Magnetic Resonance Imaging for the Diagnosis of Non-compaction Cardiomyopathy – A Case Report
New Emirates Medical Journal Radiation-Induced Pulmonary Epithelial-Mesenchymal Transition: A Review on Targeting Molecular Pathways and Mediators
Current Drug Targets Prospects of Gene Therapy for Pulmonary Diseases: Progress and Limitations
Medicinal Chemistry Impact of COVID-19 Infection on Maternal and Neonatal Outcomes: A Review of 11078 Pregnancies Reported in the Literature
Current Women`s Health Reviews Role of Alpha-1 Antitrypsin (AAT) in Ocular Allergy and Uveitis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Involvement of Cannabinoids in Cellular Proliferation
Mini-Reviews in Medicinal Chemistry Facing the threat of Antifungal Resistance: Report from the 7th Trends in Medical Mycology (TIMM-7) 9-12 October 2015, Lisbon, Portugal
Anti-Infective Agents Inflammation in Asthma Pathogenesis: Role of T Cells, Macrophages, Epithelial Cells and Type 2 Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Peptide-Based Allergen Specific Immunotherapy for the Treatment of Allergic Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Non-Ribosomal Halogenated Protease Inhibitors from Cyanobacterial Isolates as Attractive Drug Targets
Current Medicinal Chemistry Eicosanoids as Therapeutic Targets in Asthma
Letters in Drug Design & Discovery New Insights about Regulatory T Cells Distribution and Function with Exercise: The Role of Immunometabolism
Current Pharmaceutical Design G Protein-Coupled Receptors and their Signaling Pathways: Classical Therapeutical Targets Susceptible to Novel Therapeutic Concepts
Current Pharmaceutical Design Immunomodulatory Activity of Garlic
Current Immunology Reviews (Discontinued) Globalization of Clinical Trials – Where are We Heading?
Current Clinical Pharmacology